Baseline and treatment-induced change of salivary CYFRA 21 − 1 as independent predictors of recurrence in oral squamous cell carcinoma
Clinical Oral Investigations · 2026
DOI: 10.1007/s00784-026-06967-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oral Investigations, 2026. Verfasst von Aleksandar Stamatoski und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dentistry, University Clinic for Maxillofacial Surgery, Ss. Cyril and Methodius University in Skopje, Majka Tereza 17, Skopje, 1000, North…. Hauptthemen laut MEDLINE: Keratin-19, Antigens, Neoplasm, Neoplasm Recurrence, Local, Saliva. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Cytokeratin 19 fragment (CYFRA 21 - 1) has shown diagnostic utility in oral squamous cell carcinoma (OSCC), but its prognostic value and treatment-induced dynamics remain unclear. This study evaluated baseline and early post-treatment salivary and serum CYFRA 21 - 1 concentrations in patients with OSCC to assess associations with clinicopathological characteristics and recurrence-free survival. MATERIALS AND METHODS: We prospectively enrolled 40 patients with primary, resectable OSCC and measured salivary and serum CYFRA 21 - 1 by ELISA before surgery and 14 days post-operatively. The primary outcome was recurrence-free survival. RESULTS: Pretreatment salivary CYFRA 21 - 1 was higher in T3-4 versus T1-2 tumors (p = 0.033) and associated with nodal metastasis (p = 0.040). Surgical resection significantly reduced CYFRA 21 - 1 levels. However, larger absolute reductions in salivary levels (≥ 0.74 ng/mL) predicted higher recurrence risk (OR = 6.09), as did elevated baseline salivary CYFRA 21 - 1 (≥ 2.66 ng/mL; OR = 9.35). Both metrics independently predicted recurrence-free survival in multivariate Cox regression (HR = 3.00-4.10), while standard clinical factors including TNM stage and nodal status did not. Salivary and serum CYFRA 21 - 1 correlated weakly to moderately (r = 0.33, p < 0.05). CONCLUSIONS: Baseline salivary CYFRA 21 - 1 and large post-treatment reductions independently predicted OSCC recurrence, outperforming TNM staging in multivariate analysis. Larger CYFRA 21 - 1 reductions were associated with increased relapse risk, potentially reflecting aggressive tumor biology, though this counterintuitive finding requires validation in larger independent cohorts before definitive mechanistic conclusions can be drawn. Monitoring CYFRA 21 - 1 kinetics may provide biologically informed prognostication beyond anatomical classification. CLINICAL RELEVANCE: Salivary CYFRA 21 - 1 offers a non-invasive biomarker for postoperative risk stratification that could guide personalized surveillance strategies, enabling early identification of high-risk patients who may benefit from intensified follow-up or adjuvant therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Dentistry, University Clinic for Maxillofacial Surgery, Ss. Cyril and Methodius University in Skopje, Majka Tereza 17, Skopje, 1000, North Macedonia.
- Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University in Skopje, Arhimedova 3, Skopje, 1000, North Macedonia.
- Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University in Skopje, Arhimedova 3, Skopje, 1000, North Macedonia. nikola@pmf.ukim.mk.
Zitieren
APA
Stamatoski, A., Monevska, D. P., Pancevski, G., Dvojakovska, S., Iliev, A., Kirkov, A., Koneski, F., Idoska, S., Taseva, H., Mladenov, M., & Hadzi-Petrushev, N. (2026). Baseline and treatment-induced change of salivary CYFRA 21 − 1 as independent predictors of recurrence in oral squamous cell carcinoma. Clinical Oral Investigations. https://doi.org/10.1007/s00784-026-06967-9
Vancouver
Stamatoski A, Monevska DP, Pancevski G, Dvojakovska S, Iliev A, Kirkov A, et al. Baseline and treatment-induced change of salivary CYFRA 21 − 1 as independent predictors of recurrence in oral squamous cell carcinoma. Clinical Oral Investigations. 2026. doi:10.1007/s00784-026-06967-9
BibTeX
@article{Stamatoski2026,
author = {Stamatoski, Aleksandar and Monevska, Danica Popovik and Pancevski, Goran and Dvojakovska, Suzana and Iliev, Aleksandar and Kirkov, Antonio and Koneski, Filip and Idoska, Sanela and Taseva, Hristina and Mladenov, Mitko and Hadzi-Petrushev, Nikola},
title = {Baseline and treatment-induced change of salivary CYFRA 21 − 1 as independent predictors of recurrence in oral squamous cell carcinoma},
journal = {Clinical Oral Investigations},
year = {2026},
doi = {10.1007/s00784-026-06967-9}
}
EUVIMED